Ticker

Buda Juice remains a 'sell,' as the current valuation at ~8x sales is unjustified given modest growth and execution risks. Country Fresh's distribution partnership offers scale, but minority shareholders face the risk of value leakage and lack of upside optionality. FY 2025 revenue reached $12.6M, well below full capacity, with gross margin contracting to 44.4% and FCF yield just over 2.3%.

DALLAS--(BUSINESS WIRE)---- $BUDA #UltraFresh--Buda Juice, Inc. (NYSE American: BUDA), $BUDA, creator and pioneer of the Ultra Fresh category in the supermarket fresh perimeter, today reported financial results for the year ended December 31, 2025. Horatio Lonsdale-Hands, Co-Founder and Chief Executive Officer of Buda Juice, commented: “Fiscal 2025 was an important year for Buda Juice. We delivered double-digit…

Dallas, TX, March 12, 2026 (GLOBE NEWSWIRE) -- Buda Juice, Inc. (NYSE American: BUDA), $BUDA, pioneer of the new UltraFresh™ juice category for the supermarket fresh produce department with its cold-crafted, UltraFresh™ lemonades and citrus juices, today announced it intends to issue a press release before market open and host a conference call on Thursday, March 26, 2026, at 11:30 a.m. Eastern Time to discuss its…

BUDA's (NYSEAMERICAN:BUDA - Get Free Report) quiet period will expire on Tuesday, February 17th. BUDA had issued 2,666,667 shares in its IPO on January 8th. The total size of the offering was $20,000,003 based on an initial share price of $7.50. During BUDA's quiet period, underwriters and any insiders involved in the IPO are restricted

Buda Juice is a newly public, founder-led organic juice company with a volatile, low-float stock and strong initial margins. BUDA's asset-light, Texas-centric model yields 31%+ EBITDA margins, but scaling nationwide risks margin compression and higher SG&A. Valuation appears stretched at ~26.6x EBITDA; fair value estimates ($6.70–$8.70) imply 15% downside from current levels.